Orphan Drugs
-
How can orphan drug manufacturers combine pricing and market access strategies with health economics to optimize pricing and market access?
Heemstra H., Heeg B. and Botteman M. Next Generation Pharmaceutical. 2010; Q3; 92-93. Link to pdf.
|
,
View by subject
|